Experimental models for the study of hepatoprotection.
In the therapy of chronic liver diseases several drugs are currently used. This review summarizes the results of the authors in the therapy of chronic liver diseases with cyanidanol-3, as well as the beneficial effects of the new dihydroquinoline-type antioxidants in acute carbon tetrachloride induced and galactosamine induced liver lesions. In addition, the immunostimulant effects of Aicaphosphate is demonstrated in chronic active hepatitis.
D000818:Animals; D002392:Catechin / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy; D002908:Chronic Disease; D004798:Enzymes / Q000097:blood; D006098:Granulocytes / Q000187:drug effects / Q000201:enzymology; D006521:Hepatitis, Chronic / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008107:Liver Diseases / Q000188:drug therapy* / Q000201:enzymology; D008247:Lysosomes / Q000187:drug effects / Q000201:enzymology; D008315:Malondialdehyde / Q000378:metabolism; D051379:Mice; D011804:Quinolines / Q000627:therapeutic use
D004798:Enzymes; D011804:Quinolines; C011923:6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline); D008315:Malondialdehyde; D002392:Catechin; C044964:6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline)